Ceramide Analog 5cc Overcomes TRAIL Resistance by Enhancing JNK Activation and Repressing XIAP Expression in Metastatic Colon Cancer Cells

2.

Wang

S

,

El-Deiry

WS

.

Trail and apoptosis induction by tnf-family death receptors

.

Oncogene

.

2003

;

22

(

53

):

8628

–

33

.

3.

MacFarlane

M

.

Trail-induced signalling and apoptosis

.

Toxicol Lett

.

2003

139

2–3

89

97

.

4.

Forero-Torres

A

,

Infante

JR

,

Waterhouse

D

,

Wong

L

,

Vickers

S

,

Arrowsmith

E

.

Phase 2, multicenter, open-label study of tigatuzumab (cs-1008), a humanized monoclonal antibody targeting death receptor 5, in combination with gemcitabine in chemotherapy-naive patients with unresectable or metastatic pancreatic cancer

.

Cancer Med

.

2013

;

2

(

6

):

925

–

32

.

5.

Herbst

RS

,

Eckhardt

SG

,

Kurzrock

R

,

Ebbinghaus

S

,

O'Dwyer

PJ

,

Gordon

MS

.

Phase i dose-escalation study of recombinant human apo2l/trail, a dual proapoptotic receptor agonist, in patients with advanced cancer

.

J Clin Oncol

.

2010

;

28

(

17

):

2839

–

46

.

6.

Stuckey

DW

,

Shah

K

.

Trail on trial: preclinical advances in cancer therapy

.

Trends MOL MED

.

2013

;

19

(

11

):

685

–

94

.

7.

Maksimovic-Ivanic

D

,

Stosic-Grujicic

S

,

Nicoletti

F

,

Mijatovic

S

.

Resistance to trail and how to surmount it

.

Immunol Res

.

2012

52

1–2

157

68

.

8.

Rahman

M

,

Pumphrey

JG

,

Lipkowitz

S

.

The trail to targeted therapy of breast cancer

.

Adv Cancer Res

.

2009

;

103

:

43

–

73

.

9.

Cummins

JM

,

Kohli

M

,

Rago

C

,

Kinzler

KW

,

Vogelstein

B

,

Bunz

F

.

X-linked inhibitor of apoptosis protein (xiap) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (trail)-mediated apoptosis in human cancer cells

.

Cancer Res

.

2004

;

64

(

9

):

3006

–

8

.

10.

Bratton

SB

,

Cohen

GM

.

Death receptors leave a caspase footprint that smacs of xiap

.

Cell Death Differ

.

2003

;

10

(

1

):

4

–

6

.

11.

Bode

AM

,

Dong

Z

.

The functional contrariety of jnk

.

Mol Carcinog

.

2007

;

46

(

8

):

591

–

8

.

12.

Gkouveris

I

,

Nikitakis

NG

.

Role of jnk signaling in oral cancer: a mini review

.

Tumour Biol

.

2017

;

39

(

6

):

1010428317711659

.

13.

Oh

HL

,

Seok

JY

,

Kwon

CH

,

Kang

SK

,

Kim

YK

.

Role of mapk in ceramide-induced cell death in primary cultured astrocytes from mouse embryonic brain

.

Neurotoxicology

.

2006

;

27

(

1

):

31

–

8

.

14.

Brindley

GS

.

An implant for occluding arteries

.

J Physiol

.

1975

246

2

28P

30P

.

15.

Zhang

TH

,

Liu

JF

,

Zhang

Y

,

Li

YL

,

Lu

HT

,

Murata

NM

.

Ceramide induces apoptosis in human lung adenocarcinoma a549 cells through mitogen-activated protein kinases

.

Acta Pharmacol Sin

.

2007

;

28

(

3

):

439

–

45

.

16.

Qiu

L

,

Zhou

C

,

Sun

Y

,

Di

W

,

Scheffler

E

,

Healey

S

.

Paclitaxel and ceramide synergistically induce cell death with transient activation of egfr and erk pathway in pancreatic cancer cells

.

Oncol Rep

.

2006

;

16

(

4

):

907

–

13

.

17.

Kong

JY

,

Klassen

SS

,

Rabkin

SW

.

Ceramide activates a mitochondrial p38 mitogen-activated protein kinase: a potential mechanism for loss of mitochondrial transmembrane potential and apoptosis

.

Mol Cell Biochem

.

2005

278

1–2

39

51

.

18.

Stoica

BA

,

Movsesyan

VA

,

Knoblach

SM

,

Faden

AI

.

Ceramide induces neuronal apoptosis through mitogen-activated protein kinases and causes release of multiple mitochondrial proteins

.

Mol Cell Neurosci

.

2005

;

29

(

3

):

355

–

71

.

19.

Mahalingam

D

,

Keane

M

,

Pirianov

G

,

Mehmet

H

,

Samali

A

,

Szegezdi

E

.

Differential activation of jnk1 isoforms by trail receptors modulate apoptosis of colon cancer cell lines

.

Br J Cancer

.

2009

;

100

(

9

):

1415

–

24

.

20.

Maundrell

K

,

Antonsson

B

,

Magnenat

E

,

Camps

M

,

Muda

M

,

Chabert

C

.

Bcl-2 undergoes phosphorylation by c-jun n-terminal kinase/stress-activated protein kinases in the presence of the constitutively active gtp-binding protein rac1

.

J Biol Chem

.

1997

;

272

(

40

):

25238

–

42

.

21.

Chen

L

,

Meng

Y

,

Guo

X

,

Sheng

X

,

Tai

G

,

Zhang

F

.

Gefitinib enhances human colon cancer cells to trail-induced apoptosis of via autophagy- and jnk-mediated death receptors upregulation

.

Apoptosis

.

2016

;

21

(

11

):

1291

–

301

.

22.

Ogretmen

B

.

Sphingolipid metabolism in cancer signalling and therapy

.

Nat Rev Cancer

.

2018

;

18

(

1

):

33

–

50

.

23.

Liu

Q

,

Li

X

,

Bao

YS

,

Lu

J

,

Li

H

,

Huang

Z

.

Chemical synthesis and functional characterization of a new class of ceramide analogues as anti-cancer agents

.

Bioorg Med Chem

.

2019

;

27

(

8

):

1489

–

96

.

24.

Yang

D

,

Wang

S

,

Brooks

C

,

Dong

Z

,

Schoenlein

PV

,

Kumar

V

.

Ifn regulatory factor 8 sensitizes soft tissue sarcoma cells to death receptor-initiated apoptosis via repression of flice-like protein expression

.

Cancer Res

.

2009

;

69

(

3

):

1080

–

8

.

25.

Li

X

,

Zeng

X

,

Sun

J

,

Li

H

,

Wu

P

,

Fung

KP

.

Imperatorin induces mcl-1 degradation to cooperatively trigger bax translocation and bak activation to suppress drug-resistant human hepatoma

.

Cancer Lett

.

2014

348

1–2

146

55

.

26.

Muhlenbeck

F

,

Haas

E

,

Schwenzer

R

,

Schubert

G

,

Grell

M

,

Smith

C

.

Trail/apo2l activates c-jun nh2-terminal kinase (jnk) via caspase-dependent and caspase-independent pathways

.

J Biol Chem

.

1998

;

273

(

49

):

33091

–

8

.

27.

Herr

I

,

Wilhelm

D

,

Meyer

E

,

Jeremias

I

,

Angel

P

,

Debatin

KM

.

Jnk/sapk activity contributes to trail-induced apoptosis

.

Cell Death Differ

.

1999

;

6

(

2

):

130

–

5

.

28.

Corazza

N

,

Jakob

S

,

Schaer

C

,

Frese

S

,

Keogh

A

,

Stroka

D

.

Trail receptor-mediated jnk activation and bim phosphorylation critically regulate fas-mediated liver damage and lethality

.

J Clin Invest

.

2006

;

116

(

9

):

2493

–

9

.

29.

Kudriaeva

AA

,

Belogurov

AA

.

Proteasome: a nanomachinery of creative destruction

.

Biochemistry

.

2019

84

Suppl 1

S159

S192

.

30.

Guo

N

,

Peng

Z

.

Mg132, a proteasome inhibitor, induces apoptosis in tumor cells

.

Asia-Pac J Clin Onco

.

2013

;

9

(

1

):

6

–

11

.

31.

Chauhan

D

,

Li

G

,

Hideshima

T

,

Podar

K

,

Mitsiades

C

,

Mitsiades

N

.

Jnk-dependent release of mitochondrial protein, smac, during apoptosis in multiple myeloma (mm) cells

.

J Biol Chem

.

2003

;

278

(

20

):

17593

–

6

.

32.

Tang

G

,

Minemoto

Y

,

Dibling

B

,

Purcell

NH

,

Li

Z

,

Karin

M

.

Inhibition of jnk activation through nf-kappab target genes

.

Nature

.

2001

;

414

(

6861

):

313

–

7

.

33.

Ashkenazi

A

,

Pai

RC

,

Fong

S

,

Leung

S

,

Lawrence

DA

,

Marsters

SA

.

Safety and antitumor activity of recombinant soluble apo2 ligand

.

J Clin Invest

.

1999

;

104

(

2

):

155

–

62

.

34.

Wagner

KW

,

Punnoose

EA

,

Januario

T

,

Lawrence

DA

,

Pitti

RM

,

Lancaster

K

.

Death-receptor o-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand apo2l/trail

.

Nat Med

.

2007

;

13

(

9

):

1070

–

7

.

35.

Stolfi

C

,

Pallone

F

,

Monteleone

G

.

Molecular targets of trail-sensitizing agents in colorectal cancer

.

Int J Mol Sci

.

2012

;

13

(

7

):

7886

–

901

.

36.

Trivedi

R

,

Mishra

DP

.

Trailing trail resistance: novel targets for trail sensitization in cancer cells

.

Front Oncol

.

2015

;

5

:

69

.

37.

Senbabaoglu

F

,

Cingoz

A

,

Kaya

E

,

Kazancioglu

S

,

Lack

NA

,

Acilan

C

.

Identification of mitoxantrone as a trail-sensitizing agent for glioblastoma multiforme

.

Cancer Biol Ther

.

2016

;

17

(

5

):

546

–

57

.

38.

de Wilt

LH

,

Kroon

J

,

Jansen

G

,

de Jong

S

,

Peters

GJ

,

Kruyt

FA

.

Bortezomib and trail: a perfect match for apoptotic elimination of tumour cells

.

Crit Rev Oncol Hemat

.

2013

;

85

(

3

):

363

–

72

.

39.

Feng

C

,

Han

X

,

Chi

L

,

Sun

J

,

Gong

F

,

Shen

Y

.

Synthesis, characterization, and in vitro evaluation of trail-modified, cabazitaxel -loaded polymeric micelles for achieving synergistic anticancer therapy

.

J Biomat Sci-Polym E

.

2018

;

29

(

14

):

1729

–

44

.

40.

Gross

S

,

Rahal

R

,

Stransky

N

,

Lengauer

C

,

Hoeflich

KP

.

Targeting cancer with kinase inhibitors

.

J Clin Invest

.

2015

;

125

(

5

):

1780

–

9

.

41.

Kim

I

,

Byeon

HJ

,

Kim

TH

,

Lee

ES

,

Oh

KT

,

Shin

BS

.

Doxorubicin-loaded porous plga microparticles with surface attached trail for the inhalation treatment of metastatic lung cancer

.

Biomaterials

.

2013

;

34

(

27

):

6444

–

53

.

42.

Fugio

LB

,

Coeli-Lacchini

FB

,

Leopoldino

AM

.

Sphingolipids and mitochondrial dynamic

.

Cells

.

2020

;

9

(

3

):

581

.

43.

Saddoughi

SA

,

Garrett-Mayer

E

,

Chaudhary

U

,

O'Brien

PE

,

Afrin

LB

,

Day

TA

.

Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C-ceramide as a novel biomarker for monitoring response

.

Clin Cancer Res

.

2011

;

17

(

18

):

6097

–

105

.

44.

Deng

X

,

Yin

X

,

Allan

R

,

Lu

DD

,

Maurer

CW

,

Haimovitz-Friedman

A

.

Ceramide biogenesis is required for radiation-induced apoptosis in the germ line of c. Elegans

.

Science

.

2008

;

322

(

5898

):

110

–

5

.

45.

Li

RZ

,

Wang

XR

,

Wang

J

,

Xie

C

,

Wang

XX

,

Pan

HD

.

The key role of sphingolipid metabolism in cancer: new therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance

.

Front Oncol

.

2022

;

12

:

941643

.

46.

Thapa

B

,

Kc

R

,

Uludağ

H

.

Trail therapy and prospective developments for cancer treatment

.

J Control Release

.

2020

;

326

:

335

–

49

.

47.

Paschall

AV

,

Zimmerman

MA

,

Torres

CM

,

Yang

D

,

Chen

MR

,

Li

X

.

Ceramide targets xiap and ciap1 to sensitize metastatic colon and breast cancer cells to apoptosis induction to suppress tumor progression

.

Bmc Cancer

.

2014

;

14

:

24

.

48.

Zhang

X

,

Li

B

,

Zhang

Y

,

Liu

J

.

Ceramide induces release of mitochondrial proapoptotic proteins in caspase-dependent and -independent manner in ht-29 cells

.

Sci China C Life Sci

.

2008

;

51

(

1

):

66

–

71

.

49.

Saraei

R

,

Soleimani

M

,

Movassaghpour Akbari

AA

,

Farshdousti Hagh

M

,

Hassanzadeh

A

,

Solali

S

.

The role of xiap in resistance to tnf-related apoptosis-inducing ligand (trail) in leukemia

.

Biomed Pharmacother

.

2018

;

107

:

1010

–

9

.

50.

Allensworth

JL

,

Aird

KM

,

Aldrich

AJ

,

Batinic-Haberle

I

,

Devi

GR

.

Xiap inhibition and generation of reactive oxygen species enhances trail sensitivity in inflammatory breast cancer cells

.

Mol Cancer Ther

.

2012

;

11

(

7

):

1518

–

27

.

51.

Hu

WH

,

Johnson

H

,

Shu

HB

.

Tumor necrosis factor-related apoptosis-inducing ligand receptors signal nf-kappab and jnk activation and apoptosis through distinct pathways

.

J Biol Chem

.

1999

;

274

(

43

):

30603

–

10

.

52.

Yabu

T

,

Shiba

H

,

Shibasaki

Y

,

Nakanishi

T

,

Imamura

S

,

Touhata

K

.

Stress-induced ceramide generation and apoptosis via the phosphorylation and activation of nsmase1 by jnk signaling

.

Cell Death Differ

.

2015

;

22

(

2

):

258

–

73

.

53.

Verheij

M

,

Bose

R

,

Lin

XH

,

Yao

B

,

Jarvis

WD

,

Grant

S

.

Requirement for ceramide-initiated sapk/jnk signalling in stress-induced apoptosis

.

Nature

.

1996

;

380

(

6569

):

75

–

9

.

54.

Bai

L

,

Smith

DC

,

Wang

S

.

Small-molecule smac mimetics as new cancer therapeutics

.

Pharmacol Ther

.

2014

;

144

(

1

):

82

–

95

.

55.

Tsai

YT

,

Huang

HC

,

Kao

ST

,

Chang

TT

,

Cheng

CY

.

Neuroprotective effects of alpinia oxyphylla miq against mitochondria-related apoptosis by the interactions between upregulated p38 mapk signaling and downregulated jnk signaling in the subacute phase of cerebral ischemia-reperfusion in rats

.

Am J Chin Med

.

2022

;

50

(

8

):

2057

–

83

.